Login

Sommet BFM patrimoine/CNCGP – Gay-Lussac Gestion | Louis de FELS, MD, Gay-Lussac Gestion SAAS OF 30 JUN 2023 00:10:00

Share On Facebook Share On Twitter

Louis De FELS is the MD of Gay-Lussac Gestion

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
In-Depth Analysis with Chuck Royce: Strategic Positioning and Performance of High-Quality Holdings at Royce Investment Partners
00:10:00
Keystone Global Network Helped Me Overcome My Visa Challenges and Secure a Scholarship
00:10:00
CEO of the Year Kevin Ford on Techopia Live: Leadership Tips & Calian's Future | Kevin Ford - CEO of Calian Group Ltd.
00:10:00
Browder Capital is a VC Firm led by Joshua Browder|Joshua Browder,Founder,Browder Capital
00:10:00
Revolutionizing Mining: A Conversation with Dustin Angelo, CEO of Novamera | Dustin Angelo - PRESIDENT, CEO AND CO-FOUNDER of Novamera Inc.
00:10:00
We aim to advance Catholic education in the Archdiocese of Philadelphia through innovative programs and projects initiated by Catholic schools, colleges, parishes, and religious and other Catholic-focused organizations. We provide financial support and as
00:10:00
Prospect Capital's Growth Strategies and Investment Expertise
00:10:00
Optiscan is featured in Health Leader TV 2022, highlighting its live microscopic imaging technology's role in enhancing healthcare efficiency and patient outcomes.|Dr Camile Farah (PhD, MBA, MAICD, FAIM, FLWA) is CEO & Managing Director of Optiscan Imagin
00:10:00
Catalyst Metals Revitalizes WA Gold Belt and Expands Bendigo Goldfield Exploration
00:10:00
Market Turbulence: Cliff Asness Discusses Inflation, Interest Rates, and Recession Fears
00:10:00
Exploration and Milestones in West Africa: Insights from a One-to-One Conference
00:10:00
Sondrel (Holdings) PLC presents its investor update, while the CEO of Teleperformance cautions that AI lacks common sense in decision-making.

© 2017 - Neuhu+